Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

Completed · Phase 4 · Has a placebo group

Conditions studied: Osteoarthritis, Knee, Osteoarthritis, Hip

In brief

To determine whether "continuous use" of celecoxib over a 6-month period is more efficacious than "usual or intermittent use" in preventing spontaneous osteoarthritis flares of the knee and hip.

Key facts

Study ID

NCT00139776

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

875

Starts

2005-07-01

Expected to finish

2008-02-01

Last updated by the study team

2021-03-29

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject has been diagnosed, according to American College of Rheumatology guidelines, with osteoarthritis of the hip or knee and requires non-steroidal anti-inflammatory drugs (NSAIDs) to control their osteoarthritis pain and have access to a touch-tone telephone.

You may not qualify if…

• Subject has had surgery on index joint.
• Subject has history of rheumatoid arthritis or fibromyalgia syndrome.
• Subject has active gastrointestinal or cardiovascular disease.

Where it is running

• Pfizer Investigational Site — Peoria, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Anaheim, California, United States
• Pfizer Investigational Site — Huntington Beach, California, United States
• Pfizer Investigational Site — Long Beach, California, United States
• Pfizer Investigational Site — Orange, California, United States
• Pfizer Investigational Site — Paramount, California, United States
• Pfizer Investigational Site — Stockton, California, United States
• Pfizer Investigational Site — Tustin, California, United States
• Pfizer Investigational Site — Walnut Creek, California, United States
• Pfizer Investigational Site — Whittier, California, United States
• Pfizer Investigational Site — Wheat Ridge, Colorado, United States
• Pfizer Investigational Site — Danbury, Connecticut, United States
• Pfizer Investigational Site — New Milford, Connecticut, United States
• Pfizer Investigational Site — Waterbury, Connecticut, United States
• Pfizer Investigational Site — Ocala, Florida, United States
• Pfizer Investigational Site — Palm Harbor, Florida, United States
• Pfizer Investigational Site — South Miami, Florida, United States
• Pfizer Investigational Site — Tampa, Florida, United States
• Pfizer Investigational Site — Zephyrhills, Florida, United States
• Pfizer Investigational Site — Decatur, Georgia, United States
• Pfizer Investigational Site — Springfield, Illinois, United States
• Pfizer Investigational Site — Dubuque, Iowa, United States
• Pfizer Investigational Site — Dubuque, Iowa, United States
• Pfizer Investigational Site — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.